How do you counsel post-menopausal patients with HR+ breast cancer who are interested in taking medroxyprogesterone?

Assuming the woman is taking this as hormone replacement therapy for menopausal symptoms, I would recommend against this. Based on several analyses of hormone replacement and breast cancer incidence (primary prevention), including the results of the Women's Health Initiative randomized trials, conju...